SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The study will involve administering a single dose of investigational drug or placebo in
ascending dose cohorts. This study is designed to evaluate the safety and tolerability of
investigational drug as well as the efficacy of investigational drug versus placebo in adults
with primary (first episode) Clostridium difficile infection (CDI).